3 European Stocks Estimated To Be Trading Up To 48.2% Below Intrinsic Value

As European markets navigate a landscape marked by volatility and concerns over AI disruption, the pan-European STOXX Europe 600 Index recently reached a new high before settling with modest gains. Amidst these fluctuations, identifying stocks trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est) Troax Group (OM:TROAX) SEK95.60 SEK189.08 49.4% Palfinger (WBAG:PAL) €39.80 €78.37 49.2% Neste Oyj (HLSE:NESTE) €20.75 €41.08 49.5% Lectra (ENXTPA:LSS) €20.05 €40.09 50% Grieg Seafood (OB:GSF) NOK72.40 NOK143.53 49.6% Galderma Group (SWX:GALD) CHF152.20 CHF299.37 49.2% Endúr (OB:ENDUR) NOK102.20 NOK200.06 48.9% Circle (BIT:CIRC) €8.98 €17.60 49% B&S Group (ENXTAM:BSGR) €5.85 €11.66 49.8% Boreo Oyj (HLSE:BOREO) €16.50 €32.48 49.2%

Click here to see the full list of 195 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

Avadel Pharmaceuticals

Overview: Avadel Pharmaceuticals plc is a biopharmaceutical company operating in the United States with a market cap of €2.12 billion.

Operations: The company generates revenue of $248.52 million from the development and commercialization of pharmaceutical products in the United States.

Estimated Discount To Fair Value: 48.2%

Avadel Pharmaceuticals, recently acquired by Alkermes for $1.8 billion, is trading significantly below its estimated future cash flow value of €34.93 per share, indicating potential undervaluation. Despite recent insider selling and index removals, Avadel's revenue is forecast to grow at 14.5% annually, outpacing the German market's 5.9%. The company is expected to achieve profitability within three years, presenting a compelling opportunity based on cash flow valuation metrics in Europe.

Our earnings growth report unveils the potential for significant increases in Avadel Pharmaceuticals' future results. Take a closer look at Avadel Pharmaceuticals' balance sheet health here in our report.DB:AWK Discounted Cash Flow as at Feb 2026

Colt CZ Group

Overview: Colt CZ Group SE, along with its subsidiaries, manufactures and sells firearms, ammunition products, and tactical accessories across various regions including the Czech Republic, Canada, the United States, Europe, Africa, Asia and other international markets; it has a market cap of CZK51.74 billion.

Operations: The company's revenue is derived from two main segments: CZK13.16 billion from firearms and accessories, and CZK11.24 billion from ammunition products.

Story Continues

Estimated Discount To Fair Value: 38.8%

Colt CZ Group is trading at CZK826, significantly below its estimated future cash flow value of CZK1349.88, highlighting potential undervaluation. Despite a high debt level, the company demonstrates strong financial performance with earnings growing 37% over the past year and forecasted to grow 54% annually, outpacing the Czech market's growth. Recent earnings reports show increased sales and net income compared to last year, reinforcing its robust cash flow position in Europe.

The growth report we've compiled suggests that Colt CZ Group's future prospects could be on the up. Unlock comprehensive insights into our analysis of Colt CZ Group stock in this financial health report.SEP:CZG Discounted Cash Flow as at Feb 2026

Zehnder Group

Overview: Zehnder Group AG, with a market cap of CHF1.00 billion, develops, manufactures, and sells indoor climate systems across Europe, North America, and China.

Operations: The company's revenue is derived from two main segments: Radiators, generating €269.80 million, and Ventilation, contributing €474.10 million.

Estimated Discount To Fair Value: 10.2%

Zehnder Group's recent sales growth to €760.7 million in 2025, aided by the Siber acquisition and market share gains, underscores its strategic positioning despite challenges in the radiator segment. Trading at CHF90.3, it's slightly undervalued compared to a future cash flow estimate of CHF100.51. Forecasts suggest robust earnings growth of 35.5% annually over three years, outpacing Swiss market expectations and reinforcing its potential as an undervalued stock based on cash flows.

The analysis detailed in our Zehnder Group growth report hints at robust future financial performance. Dive into the specifics of Zehnder Group here with our thorough financial health report.SWX:ZEHN Discounted Cash Flow as at Feb 2026

Make It Happen

Access the full spectrum of 195 Undervalued European Stocks Based On Cash Flows by clicking on this link. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Searching for a Fresh Perspective?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include DB:AWK SEP:CZG and SWX:ZEHN.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments